Nilgün Karalı (Nilgun Karali)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 19

Top Topics

Molecular Docking

Single Molecule

Top Venues

Future medicinal chemistry

Molecular informatics

Archiv der Pharmazie

This page only lists publications with an associated author ORCID identifier.

Publications

Asu Busra Temizer, Gökçe Uludoğan, Rıza Özçelik, Taha Koulani, Elif Ozkirimli, Kutlu O Ülgen, Nilgün Karalı, Arzucan Özgür
Exploring data-driven chemical SMILES tokenization approaches to identify key protein-ligand binding moieties. Molecular informatics 43 (3) (2024)
Özge Soylu-Eter, Nurten Özsoy, Nilgün Karalı
Synthesis and molecular docking studies of 5-trifluoromethoxy-2-indolinones as cholinesterase dual inhibitors. Future medicinal chemistry 16 (7) (2024)
Çağla Begüm Apaydın, Fusun Goktas, Lieve Naesens, Nilgün Karalı
Novel 2-indolinone derivatives as promising agents against respiratory syncytial and yellow fever viruses. Future medicinal chemistry 16 (4) (2024)
Asu Busra Temizer, Gökçe Uludoğan, Rıza Özçelik, Taha Koulani, Elif Ozkirimli, Kutlu O Ülgen, Nilgün Karalı, Arzucan Özgür
Exploring data-driven chemical SMILES tokenization approaches to identify key protein-ligand binding moieties. Molecular informatics (2024)
Özge Soylu-Eter, Nurten Özsoy, Nilgün Karalı
Synthesis and molecular docking studies of 5-trifluoromethoxy-2-indolinones as cholinesterase dual inhibitors. Future medicinal chemistry 16 (7) (2024)
Asu Busra Temizer, Gökçe Uludoğan, Rıza Özçelik, Taha Koulani, Elif Ozkirimli, Kutlu O Ülgen, Nilgün Karalı, Arzucan Özgür
Exploring data-driven chemical SMILES tokenization approaches to identify key protein-ligand binding moieties. Molecular informatics (2024)
Çağla Begüm Apaydın, Fusun Goktas, Lieve Naesens, Nilgün Karalı
Novel 2-indolinone derivatives as promising agents against respiratory syncytial and yellow fever viruses. Future medicinal chemistry 16 (4) (2024)
Asu Busra Temizer, Gökçe Uludoğan, Rıza Özçelik, Taha Koulani, Elif Ozkirimli, Kutlu O Ülgen, Nilgün Karalı, Arzucan Özgür
Exploring data-driven chemical SMILES tokenization approaches to identify key protein-ligand binding moieties. Molecular informatics 43 (3) (2024)
Çağla Begüm Apaydın, Fusun Goktas, Lieve Naesens, Nilgün Karalı
Novel 2-indolinone derivatives as promising agents against respiratory syncytial and yellow fever viruses. Future medicinal chemistry 16 (4) (2024)
Çağla Begüm Apaydın, Fusun Goktas, Lieve Naesens, Nilgün Karalı
Novel 2-indolinone derivatives as promising agents against respiratory syncytial and yellow fever viruses. Future medicinal chemistry 16 (4) (2024)
Çağla Begüm Apaydın, Fusun Goktas, Lieve Naesens, Nilgün Karalı
Novel 2-indolinone derivatives as promising agents against respiratory syncytial and yellow fever viruses. Future medicinal chemistry (2024)
Özge Soylu-Eter, Nurten Özsoy, Nilgün Karalı
Synthesis and molecular docking studies of 5-trifluoromethoxy-2-indolinones as cholinesterase dual inhibitors. Future medicinal chemistry 16 (7) (2024)
Özge Soylu-Eter, Zekiye Şeyma Sevinçli, Betül Ersoy, Bahar Hasanusta, Uğur Gatfar, Nathan A Lack, Burak Erman, Ahmet Gül, Hakan S Orer, Nilgün Karalı
5-Fluoro/(trifluoromethoxy)-2-indolinone derivatives with anti-interleukin-1 activity. Archiv der Pharmazie (2023)
Çağla Begüm Apaydın, Özge Soylu-Eter, Pınar Eraslan-Elma, Nurten Özsoy, Nilgün Karalı
Synthesis and molecular modeling studies of 1-benzyl-2-indolinones as selective AChE inhibitors. Future medicinal chemistry 14 (23) (2022)
Pınar Eraslan-Elma, Atilla Akdemir, Emanuela Berrino, Murat Bozdag, Claudiu T Supuran, Nilgün Karalı
New 1H-indole-2,3-dione 3-thiosemicarbazones with 3-sulfamoylphenyl moiety as selective carbonic anhydrase inhibitors. Archiv der Pharmazie 355 (8) (2022)
Çağla Begüm Apaydın, Özge Soylu-Eter, Pınar Eraslan-Elma, Nurten Özsoy, Nilgün Karalı
Synthesis and molecular modeling studies of 1-benzyl-2-indolinones as selective AChE inhibitors. Future medicinal chemistry 14 (23) (2022)
Çağla Begüm Apaydın, Özge Soylu-Eter, Pınar Eraslan-Elma, Nurten Özsoy, Nilgün Karalı
Synthesis and molecular modeling studies of 1-benzyl-2-indolinones as selective AChE inhibitors. Future medicinal chemistry 14 (23) (2022)
Çağla Begüm Apaydın, Özge Soylu-Eter, Pınar Eraslan-Elma, Nurten Özsoy, Nilgün Karalı
Synthesis and molecular modeling studies of 1-benzyl-2-indolinones as selective AChE inhibitors. Future medicinal chemistry (2022)
Kübra Demir-Yazıcı, Çağla Begüm Apaydın, Özge Soylu-Eter, Nurten Özsoy, Nilgün Karalı
Synthesis, molecular modeling and cholinesterase inhibitory effects of 2-indolinone-based hydrazinecarbothioamides. Future medicinal chemistry 13 (24) (2021)